Origin of organisms infecting ventricular shunts
- PMID: 3380276
Origin of organisms infecting ventricular shunts
Abstract
Results of skin cultures obtained before 413 of 505 operations for cerebrospinal fluid-diverting ventricular shunt placement or revision in a pediatric population from April 1980 to May 1983 are analyzed and compared to results of cultures from 20 subsequent shunt infections. Sensitivities to 11 different antibiotics were determined for each isolate cultured. The total operative infection rate was 20 of 505 (4%). Gram-negative bacilli alone accounted for 3 of 20 (15%) shunt infections. One gram-negative bacillus/Staphylococcus aureus infection occurred. Factors predisposing for gram-negative bacillus shunt infection were found in all 4 cases. The majority of shunt infections were caused by typical resident skin organisms: Staphylococcus epidermidis alone, 9/20 (45%); Staphylococcus aureus alone, 4/20 (20%); Corynebacterium sp., 1/20 (5%); alpha-Streptococcus with S. epidermidis, 1/20 (5%); and Micrococcus with S. epidermidis, 1/20 (5%). Only 4 (20%) of the 20 shunt infections were due to organisms identical to those originally grown from the skin. Another 4 (20%) seemed to be infected with a strain of organism different from that initially recovered from the skin. The remaining skin organism shunt infections may or may not have come from the patient's skin. The data suggest that not all skin organism shunt infections arise from contamination by resident skin bacteria at the incision sites at the time of operation. Alternate sources for the infecting organisms are discussed. The antibiotic sensitivity data on skin isolates and shunt isolates suggest that vancomycin is the antibiotic best suited for prophylaxis against shunt infection at our institution.
Similar articles
-
Shunt infection: is there a near-miss scenario?J Neurosurg. 2007 Jan;106(1 Suppl):15-9. doi: 10.3171/ped.2007.106.1.15. J Neurosurg. 2007. PMID: 17233307
-
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.J Neurosurg. 2007 Sep;107(3 Suppl):213-9. doi: 10.3171/PED-07/09/213. J Neurosurg. 2007. PMID: 17918527
-
[Infection of the valves of CSF shunts. Results of local and general antibiotic treatment in 6 cases].Neurochirurgie. 1985;31(5):390-4. Neurochirurgie. 1985. PMID: 4088406 French.
-
[Antibiotic therapy of infected cerebrospinal fluid in hydrocephalus treated by a shunt].An Esp Pediatr. 1988 Dec;29(6):435-9. An Esp Pediatr. 1988. PMID: 3072889 Review. Spanish.
-
Infections of mechanical cerebrospinal fluid shunts.Curr Clin Top Infect Dis. 1988;9:185-214. Curr Clin Top Infect Dis. 1988. PMID: 3077288 Review.
Cited by
-
Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study.Childs Nerv Syst. 1991 Aug;7(4):211-4. doi: 10.1007/BF00249397. Childs Nerv Syst. 1991. PMID: 1933917
-
Long-term results after ventriculo-atrial shunting in children.Childs Nerv Syst. 1995 Mar;11(3):176-9. doi: 10.1007/BF00570261. Childs Nerv Syst. 1995. PMID: 7773980
-
Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.BMC Infect Dis. 2007 May 8;7:38. doi: 10.1186/1471-2334-7-38. BMC Infect Dis. 2007. PMID: 17488498 Free PMC article.
-
Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children.Childs Nerv Syst. 2005 Jan;21(1):56-61. doi: 10.1007/s00381-004-1052-x. Epub 2004 Oct 12. Childs Nerv Syst. 2005. PMID: 15480705 Clinical Trial.
-
Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.Acta Neurochir (Wien). 1995;136(1-2):1-7. doi: 10.1007/BF01411427. Acta Neurochir (Wien). 1995. PMID: 8748819
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous